Nitrotyrosination of endothelial α-tubulin:: Potential effects on binding of the tumour vascular-targeting agent, combretastatin A-4-P

被引:0
|
作者
Parkins, CS [1 ]
Cook, IH [1 ]
Kanthou, C [1 ]
Mapp, P [1 ]
Tozer, GM [1 ]
机构
[1] Gray Canc Inst, Tumour Microcirculat Grp, Northwood, Middx, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The intrinsic ability of endothelial cells to add or remove tyrosine and 3-nitrotyrosine to/from a-tubulin was investigated as a potential modulator of the anti-vascular action of the tubulin-binding agent, combretastatin A4-phosphate (CA-4-P). Both substrates were incorporated into a-tubulin proficiently. Subsequent incubation in deficient medium resulted in the loss of tyrosine but not 3-nitrotyrosine from endothelial tubulin. Incorporation of 3-nitrotyrosine, but not tyrosine, resulted in increased permeability of endothelial cell monolayers with similar magnitude to that evoked following tubulin-depolymerisation by CA-4-P. Immuno-histochemical 3-nitrotyrosine was present in a tumour type that responds to CA-4-P. We conclude that nitrotyrosination of a-tubulin in endothelial cells may contribute to the susceptibility of tumours to CA-4-P.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 21 条
  • [1] Efficacy of the tumour vascular targeting agent combretastatin A-4-P at clinically relevant doses
    Tozer, GM
    Honess, DJ
    Wilson, J
    Hill, SA
    Hodgkiss, RJ
    Ameer-Beg, S
    Vojnovic, B
    Prise, VE
    22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY, 2002, : 43 - 47
  • [2] Combretastatin A-4 P as a tumour vascular targeting agent
    Tozer, GM
    Prise, VE
    Wilson, J
    Vojnovic, B
    Shan, SQ
    Dewhirst, MW
    Chaplin, DJ
    BRITISH JOURNAL OF CANCER, 1998, 78 : 48 - 48
  • [3] Modifications to endothelial tubulin by nitric oxide (NO) - Response to microtubule-depolymerising agent, combretastatin A-4-P
    Parkins, CS
    Cook, IH
    Tozer, GM
    BRITISH JOURNAL OF CANCER, 2001, 85 : 33 - 33
  • [4] Therapeutic targeting of the tumour vasculature using the tubulin-binding agent combretastatin A4-P
    Tozer, GM
    Prise, VE
    Wilson, I
    Vojnovic, B
    Chaplin, DJ
    JOURNAL OF VASCULAR RESEARCH, 1999, 36 (04) : 328 - 329
  • [5] Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
    Tozer, GM
    Prise, VE
    Wilson, J
    Locke, RJ
    Vojnovic, B
    Stratford, MRL
    Dennis, MF
    Chaplin, DJ
    CANCER RESEARCH, 1999, 59 (07) : 1626 - 1634
  • [6] Vascular-targeting activity of ZD6126, a novel tubulin-binding agent
    Micheletti, G
    Poli, M
    Borsotti, P
    Martinelli, M
    Imberti, B
    Taraboletti, G
    Giavazzi, R
    CANCER RESEARCH, 2003, 63 (07) : 1534 - 1537
  • [7] Novel diaryl combretastatin analogues: Potential agents of tubulin binding and vascular targeting.
    Wehbe, H
    Pinney, KG
    Kearney, CM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U25 - U25
  • [8] Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression
    Dachs, Gabi U.
    Steele, Andrew J.
    Coralli, Claudia
    Kanthou, Chryso
    Brooks, Andrew C.
    Gunningham, Sarah P.
    Currie, Margaret J.
    Watson, Ally I.
    Robinson, Bridget A.
    Tozer, Gillian M.
    BMC CANCER, 2006, 6 (1)
  • [9] Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression
    Gabi U Dachs
    Andrew J Steele
    Claudia Coralli
    Chryso Kanthou
    Andrew C Brooks
    Sarah P Gunningham
    Margaret J Currie
    Ally I Watson
    Bridget A Robinson
    Gillian M Tozer
    BMC Cancer, 6
  • [10] Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo
    Galbraith, SM
    Chaplin, DJ
    Lee, F
    Stratford, MRL
    Locke, RJ
    Vojnovic, B
    Tozer, GM
    ANTICANCER RESEARCH, 2001, 21 (1A) : 93 - 102